Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
ContributorsDubois, Bruno; Hampel, Harald; Feldman, Howard H.; Scheltens, Philip; Aisen, Paul; Andrieu, Sandrine; Bakardjian, Hovagim; Benali, Habib; Bertram, Lars; Blennow, Kaj; Broich, Karl; Cavedo, Enrica; Crutch, Sebastian; Dartigues, Jean-François; Duyckaerts, Charles; Epelbaum, Stéphane; Frisoni, Giovanni; Gauthier, Serge; Genthon, Remy; Gouw, Alida A.; Habert, Marie-Odile; Holtzman, David M.; Kivipelto, Miia; Lista, Simone; Molinuevo, José-Luis; O'Bryant, Sid E.; Rabinovici, Gil D.; Rowe, Christopher; Salloway, Stephen; Schneider, Lon S.; Sperling, Reisa; Teichmann, Marc; Carrillo, Maria C.; Cummings, Jeffrey; Jack, Cliff R.
Published inAlzheimer's & dementia, vol. 12, no. 3, p. 292-323
Publication date2016
Abstract
Keywords
- Alzheimer's disease
- Amyloid PET
- Asymptomatic
- Biomarkers
- Blood biomarkers
- CSF biomarkers
- Diagnostic criteria
- Genetics
- MRI
- Pathophysiology
- Preclinical
- Tau PET
Affiliation entities
Research groups
Citation (ISO format)
DUBOIS, Bruno et al. Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria. In: Alzheimer’s & dementia, 2016, vol. 12, n° 3, p. 292–323. doi: 10.1016/j.jalz.2016.02.002
Main files (1)
Article (Published version)
Identifiers
- PID : unige:83551
- DOI : 10.1016/j.jalz.2016.02.002
Additional URL for this publicationhttp://linkinghub.elsevier.com/retrieve/pii/S1552526016000509
Journal ISSN1552-5260